|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 10 (May 15), 2000:
pp. 3102-3105
 2 Microglobulin-deficient (B2mnull)
NOD/SCID mice are excellent recipients for studying human stem cell
function
Orit Kollet,
Amnon Peled,
Tamara Byk,
Herzl Ben-Hur,
Dale Greiner,
Leonard Shultz, and
Tsvee Lapidot
From the Department of Immunology, The Weizmann Institute and the
Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot,
Israel; the University of Massachusetts, Worcester MA; and The Jackson
Laboratory, Bar Harbor, ME.
Human SCID repopulating cells (SRC) are defined based on their
functional ability to repopulate the bone marrow of NOD/SCID mice with
both myeloid and lymphoid cell populations. The frequency of SRC in
umbilical cord blood cells is 1 in 9.3 × 105
mononuclear cells. We report that as few as
8 × 104 human cord blood mononuclear cells transplanted
into NOD/SCID/B2mnull mice resulted in mutlilineage
differentiation in the murine bone marrow, revealing a more than
11-fold higher SRC frequency than in NOD/SCID mice. Moreover, as few as
2 to 5 × 103 CD34+ cells recovered from
the bone marrow of primary transplanted NOD/SCID mice were sufficient
for engrafting secondary NOD/SCID/B2mnull mice with
SRC, suggesting SRC self-renewal. Thus, by using
NOD/SCID/B2mnull mice as recipients, we established
a functional assay for human stem cells capable of engrafting the bone
marrow of primary and secondary transplanted immune-deficient mice with
SRC, providing a model that better resembles autologous stem cell transplantation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
G. V. Rosland, A. Svendsen, A. Torsvik, E. Sobala, E. McCormack, H. Immervoll, J. Mysliwietz, J.-C. Tonn, R. Goldbrunner, P. E. Lonning, et al.
Long-term Cultures of Bone Marrow-Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation
Cancer Res.,
July 1, 2009;
69(13):
5331 - 5339.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. M. Carreno, J. R. Garbow, G. R. Kolar, E. N. Jackson, J. A. Engelbach, M. Becker-Hapak, L. N. Carayannopoulos, D. Piwnica-Worms, and G. P. Linette
Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases
Clin. Cancer Res.,
May 15, 2009;
15(10):
3277 - 3286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Hayakawa, M. M. Hsieh, N. Uchida, O. Phang, and J. F. Tisdale
Busulfan Produces Efficient Human Cell Engraftment in NOD/LtSz-Scid IL2R{gamma}Null Mice
Stem Cells,
January 1, 2009;
27(1):
175 - 182.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Giassi, T. Pearson, L. D. Shultz, J. Laning, K. Biber, M. Kraus, B. A. Woda, M. R. Schmidt, R. T. Woodland, A. A. Rossini, et al.
Expanded CD34+ Human Umbilical Cord Blood Cells Generate Multiple Lymphohematopoietic Lineages in NOD-scid IL2r{gamma}null Mice
Experimental Biology and Medicine,
August 1, 2008;
233(8):
997 - 1012.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Liebler, C. Lutzko, A. Banfalvi, D. Senadheera, N. Aghamohammadi, E. D. Crandall, and Z. Borok
Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury
Am J Physiol Lung Cell Mol Physiol,
August 1, 2008;
295(2):
L285 - L292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Maxwell, J. Bonde, D. A. Hess, S. A. Hohm, R. Lahey, P. Zhou, M. H. Creer, D. Piwnica-Worms, and J. A. Nolta
Fluorophore-Conjugated Iron Oxide Nanoparticle Labeling and Analysis of Engrafting Human Hematopoietic Stem Cells
Stem Cells,
February 1, 2008;
26(2):
517 - 524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Watanabe, S. Ohta, M. Yajima, K. Terashima, M. Ito, H. Mugishima, S. Fujiwara, K. Shimizu, M. Honda, N. Shimizu, et al.
Humanized NOD/SCID/IL2R{gamma}null Mice Transplanted with Hematopoietic Stem Cells under Nonmyeloablative Conditions Show Prolonged Life Spans and Allow Detailed Analysis of Human Immunodeficiency Virus Type 1 Pathogenesis
J. Virol.,
December 1, 2007;
81(23):
13259 - 13264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rizo, E. Vellenga, G. de Haan, and J. J. Schuringa
Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
Hum. Mol. Genet.,
October 15, 2006;
15(suppl_2):
R210 - R219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Jaras, A. Edqvist, J. Rebetz, L. G. Salford, B. Widegren, and X. Fan
Human short-term repopulating cells have enhanced telomerase reverse transcriptase expression
Blood,
August 1, 2006;
108(3):
1084 - 1091.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Legrand, K. Weijer, and H. Spits
Experimental Models to Study Development and Function of the Human Immune System In Vivo
J. Immunol.,
February 15, 2006;
176(4):
2053 - 2058.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Pearce, D. Taussig, K. Zibara, L.-L. Smith, C. M. Ridler, C. Preudhomme, B. D. Young, A. Z. Rohatiner, T. A. Lister, and D. Bonnet
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML
Blood,
February 1, 2006;
107(3):
1166 - 1173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Lapidot, A. Dar, and O. Kollet
How do stem cells find their way home?
Blood,
September 15, 2005;
106(6):
1901 - 1910.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Ishikawa, M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice
Blood,
September 1, 2005;
106(5):
1565 - 1573.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. McKenzie, O. I. Gan, M. Doedens, and J. E. Dick
Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells
Blood,
August 15, 2005;
106(4):
1259 - 1261.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. D. Shultz, B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, et al.
Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2R{gamma}null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells
J. Immunol.,
May 15, 2005;
174(10):
6477 - 6489.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Byk, J. Kahn, O. Kollet, I. Petit, S. Samira, S. Shivtiel, H. Ben-Hur, A. Peled, W. Piacibello, and T. Lapidot
Cycling G1 CD34+/CD38+ Cells Potentiate the Motility and Engraftment of Quiescent G0 CD34+/CD38-/low Severe Combined Immunodeficiency Repopulating Cells
Stem Cells,
April 1, 2005;
23(4):
561 - 574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chadwick, F. Shojaei, L. Gallacher, and M. Bhatia
Smad7 alters cell fate decisions of human hematopoietic repopulating cells
Blood,
March 1, 2005;
105(5):
1905 - 1915.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. R. Kolar, T. Yokota, M. I. D. Rossi, S. K. Nath, and J. D. Capra
Human fetal, cord blood, and adult lymphocyte progenitors have similar potential for generating B cells with a diverse immunoglobulin repertoire
Blood,
November 1, 2004;
104(9):
2981 - 2987.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Thanopoulou, J. Cashman, T. Kakagianne, A. Eaves, N. Zoumbos, and C. Eaves
Engraftment of NOD/SCID-{beta}2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome
Blood,
June 1, 2004;
103(11):
4285 - 4293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Spiegel, O. Kollet, A. Peled, L. Abel, A. Nagler, B. Bielorai, G. Rechavi, J. Vormoor, and T. Lapidot
Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling
Blood,
April 15, 2004;
103(8):
2900 - 2907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Traggiai, L. Chicha, L. Mazzucchelli, L. Bronz, J.-C. Piffaretti, A. Lanzavecchia, and M. G. Manz
Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice
Science,
April 2, 2004;
304(5667):
104 - 107.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Kambe, H. Hiramatsu, M. Shimonaka, H. Fujino, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, Y. Ueyama, N. Matsuyoshi, et al.
Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body
Blood,
February 1, 2004;
103(3):
860 - 867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Nolta
Improved method to bridge mouse and man
Blood,
January 15, 2004;
103(2):
370 - 371.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Palucka, J. Gatlin, J. P. Blanck, M. W. Melkus, S. Clayton, H. Ueno, E. T. Kraus, P. Cravens, L. Bennett, A. Padgett-Thomas, et al.
Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors
Blood,
November 1, 2003;
102(9):
3302 - 3310.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Brenner, N. L. Whiting-Theobald, G. F. Linton, K. L. Holmes, M. Anderson-Cohen, P. F. Kelly, E. F. Vanin, A. M. Pilon, D. M. Bodine, M. E. Horwitz, et al.
Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/{beta}2-microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells
Blood,
October 15, 2003;
102(8):
2789 - 2797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Hiramatsu, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, K. Katamura, and T. Nakahata
Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/{gamma}cnull mice model
Blood,
August 1, 2003;
102(3):
873 - 880.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Wang, S. Ge, G. McNamara, Q.-L. Hao, G. M. Crooks, and J. A. Nolta
Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells
Blood,
May 15, 2003;
101(10):
4201 - 4208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ito, H. Hiramatsu, K. Kobayashi, K. Suzue, M. Kawahata, K. Hioki, Y. Ueyama, Y. Koyanagi, K. Sugamura, K. Tsuji, et al.
NOD/SCID/gamma cnull mouse: an excellent recipient mouse model for engraftment of human cells
Blood,
October 16, 2002;
100(9):
3175 - 3182.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. C. C. Kerre, G. De Smet, M. De Smedt, F. Offner, J. De Bosscher, J. Plum, and B. Vandekerckhove
Both CD34+38+ and CD34+38- Cells Home Specifically to the Bone Marrow of NOD/LtSZ scid/scid Mice but Show Different Kinetics in Expansion
J. Immunol.,
October 1, 2001;
167(7):
3692 - 3698.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Kollet, A. Spiegel, A. Peled, I. Petit, T. Byk, R. Hershkoviz, E. Guetta, G. Barkai, A. Nagler, and T. Lapidot
Rapid and efficient homing of human CD34+CD38{-}/lowCXCR4+ stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2mnull mice
Blood,
May 15, 2001;
97(10):
3283 - 3291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
